A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus

Immunology

Volumn 109, Issue 3, 2003, Pages 326-328

  Oxford, J S ^a   Bossuyt, S ^a   Lambkin, R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; MATRIX PROTEIN; NUCLEOPROTEIN; PROTEINASE; RNA DIRECTED RNA POLYMERASE; SPIKE PROTEIN; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS PROTEIN;

COMMUNITY ACQUIRED PNEUMONIA; CORONAVIRUS; DISEASE TRANSMISSION; EPIDEMIC; HONG KONG; HUMAN; INFECTION CONTROL; INFLUENZA VIRUS; INFLUENZA VIRUS A; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VIRUS DETECTION; VIRUS INFECTION;

ASIA, SOUTHEASTERN; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; HUMANS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL VACCINES;

EID: 0038127076     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01684.x     Document Type: Review

References (14)

1. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319-25.
2. Oxford JS. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virol 2000; 10:119-33.
3. Scholtissek C, Stech J, Krauss S, Webster RG. Cooperation between the hemagglutinin of avian viruses and the matrix protein of human influenza A viruses. J Virol 2002; 76: 1781-6.
4. Oxford JS, Sefton A, Jackson R, Innes W, Daniels RS, Johnson NP. World War I may have allowed the emergence of 'Spanish' influenza. Lancet Infect Dis 2002; 2:111-4.
5. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R, Cheng AF. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467-71.
6. Hampson AW. Influenza Virus Antigens and 'Antigenic Drift'. In: Potter GW, ed. Influenza. Amsterdam: Elsevier, 2002: 49-85.
7. Tyrrell DAJ, Bynoe ML. Cultivation of a novel type of common cold virus in organ culture. Br Med J 1965; 1:1467-70.
8. Siddell S, Myint S. Coronaviruses. In: Myint SH, Taylor-Robinson D, eds. Viral and Other Infections of the Human Respiratory Tract. Dordrecht: Kluwer Academic Publishers, 1995.
9. MMWR. Severe Acute Respiratory Syndrome (SARS) and coronavirus testing. MMWR 2003; 52:14-5.
10. Ruan YJ et al. Comparative full length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins and infection. Lancet 2003; (in press).
11. MacNaughton MR, Hasony HJ, Madge MH, Reed SE. Antibody to virus components in volunteers experimentally infected with human coronavirus 229E group viruses. Infect Immun 1981; 31:845-9.
12. Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 1989; 168:162-7.
13. Deregt D, Babiuk LA. Monoclonal antibodies to bovine coronavirus, characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins. Virology 1987; 161:410-20.
14. Sidwell RW. Ribavirin. Review of a Broad-Spectrum Antiviral Agent. In: Shugar D, ed. Viral Chemotherapy. Oxford: Pergamon Press 1985: 49-97.